These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6251787)

  • 1. Experimental infection and the state of viral latency of adult tupaia with herpes simplex virus type 1 and 2 and infection of juvenile Tupaia with temperature-sensitive mutants of HSV Type 2.
    Darai G; Zöller L; Matz B; Schwaier A; Flügel RM; Munk K
    Arch Virol; 1980; 65(3-4):311-8. PubMed ID: 6251787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intertypic superinfection of herpes simplex virus in vivo leads to reisolation of latent viruses with newly acquired lymphotropic properties.
    Darai G; Scholz J; Kurz W; Koch HG
    Dev Biol Stand; 1982; 52():67-80. PubMed ID: 6299861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental infection of Tupaia belangeri (tree shrews) with herpes simplex virus types 1 and 2.
    Darai G; Schwaier A; Komitowski D; Munk K
    J Infect Dis; 1978 Mar; 137(3):221-6. PubMed ID: 204709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transduction of virulence in herpes simplex virus type 1 from a pathogenic to an apathogenic strain by a cloned viral DNA fragment.
    Rösen A; Gelderblom H; Darai G
    Med Microbiol Immunol; 1985; 173(5):257-78. PubMed ID: 2982083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the virulence genes of herpes simplex virus 2 by experimental infection in vivo with defined intertypic recombinants of a virulent HSV-2 X an avirulent HSV-1.
    Rösen A; Darai G
    Med Microbiol Immunol; 1985; 174(5):237-48. PubMed ID: 3003551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary lethal invasion of the central nervous system by nonneuroinvasive herpes simplex virus types 1 and 2.
    Nishiyama Y; Kimura H; Daikoku T
    J Virol; 1991 Aug; 65(8):4520-4. PubMed ID: 1649347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus type 2 establishes latency in the mouse footpad and in the sensory ganglia.
    Subak-Sharpe JH; Al-Saadi SA; Clements GB
    J Invest Dermatol; 1984 Jul; 83(1 Suppl):67s-71s. PubMed ID: 6330225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of generalized and lethal herpesvirus infection in the tree shrew by intrahepatic transfection of herpes simplex virus DNA.
    Darai G; Rösen A; Scholz J; Gelderblom H
    J Virol Methods; 1983 Dec; 7(5-6):305-14. PubMed ID: 6330148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organotropism of latent herpes simplex virus type 1 is correlated to the presence of a 1.5 kb RNA transcript mapped within the BamHI DNA fragment B (0.738 to 0.809 map units).
    Rösen-Wolff A; Scholz J; Darai G
    Virus Res; 1989 Jan; 12(1):43-51. PubMed ID: 2541581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of mice by an apathogenic strain HSV-1 against lethal infection by a pathogenic strain of HSV-1.
    Schröeder CH; Engler H; Kirchner H
    J Gen Virol; 1981 Jan; 52(Pt 1):159-61. PubMed ID: 6267173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiologic analysis of DNA's of herpes simplex virus, type 1 and type 2 isolates obtained from family members and from different lesions of individuals].
    Ozawa S; Yoshino K; Harada S; Ishiko H; Yanagi K
    Kansenshogaku Zasshi; 1990 Jun; 64(6):674-80. PubMed ID: 2169506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus type 1 (HSV-1) UL56 gene is involved in viral intraperitoneal pathogenicity to immunocompetent mice.
    Berkowitz C; Moyal M; Rösen-Wolff A; Darai G; Becker Y
    Arch Virol; 1994; 134(1-2):73-83. PubMed ID: 8279961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes Simplex Virus 1 Infection of Tree Shrews Differs from That of Mice in the Severity of Acute Infection and Viral Transcription in the Peripheral Nervous System.
    Li L; Li Z; Wang E; Yang R; Xiao Y; Han H; Lang F; Li X; Xia Y; Gao F; Li Q; Fraser NW; Zhou J
    J Virol; 2016 Jan; 90(2):790-804. PubMed ID: 26512084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery of herpes simplex virus genetic information from human trigeminal ganglion cells following superinfection with herpes simplex virus type 2 temperature-sensitive mutants.
    Lewis ME; Brown SM; Warren KG; Subak-Sharpe JH
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():215-9. PubMed ID: 6319568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenicity in mice of herpes simplex virus type 2 mutants unable to express glycoprotein C.
    Johnson DC; McDermott MR; Chrisp C; Glorioso JC
    J Virol; 1986 Apr; 58(1):36-42. PubMed ID: 3005656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of UL56 gene by insertion of LacZ cassette between nucleotide position 116030 to 121753 of the herpes simplex virus type 1 genome abrogates intraperitoneal pathogenicity in tree shrews and mice.
    Rösen-Wolff A; Lamadé W; Berkowitz C; Becker Y; Darai G
    Virus Res; 1991 Aug; 20(3):205-21. PubMed ID: 1662844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of the HpaI-P sequence for herpes simplex virus-1 replication in the adrenal glands.
    Peles E; Rosen H; Darai G; Rösen-Wolff A; Becker Y
    Arch Virol; 1990; 113(3-4):151-63. PubMed ID: 2171454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenicity of wild-type and temperature-sensitive mutants of herpes simplex virus type 2 in guinea pigs.
    Anderson CA; August MJ; Hsiung GD
    Infect Immun; 1980 Oct; 30(1):159-69. PubMed ID: 6254877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathogenicity of herpes simplex virus in mice: protection against lethal encephalitis by co-infection with a non-encephalitogenic strain.
    Schröder CH; Kümel G; Glorioso J; Kirchner H; Kaerner HC
    J Gen Virol; 1983 Sep; 64 (Pt 9)():1973-82. PubMed ID: 6310037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ability of herpes simplex virus (HSV) types 1 and 2 to induce clinical disease and establish latency following previous genital infection with the heterologous HSV type.
    Landry ML; Zibello TA
    J Infect Dis; 1988 Dec; 158(6):1220-6. PubMed ID: 2848899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.